適用於公開取用強制性政策的文章 - Kristel Sleegers瞭解詳情
整體FWOMRCNIHSwedish Research CouncilGovernment of SpainEuropean CommissionNIHRINSERMWellcomeZonMwCIHRSNSFGovernment of ItalyDoDDFGBanking Foundation "la Caixa"Alzheimers's UKHHMINWODMTBMBFKnut and Alice Wallenberg FoundationAcademy of FinlandVAFNRSFCTESRCMotor Neurone Disease Association, UKANRAXA Research Fund, FranceBELSPOFWFNHMRCFORTERCNJDRFHelmholtzMarianne and Marcus Wallenberg FoundationHealth Data Research, UKBHFCSOEPSRCMichael J Fox FoundationNSFCBank of Sweden Tercentenary FoundationA*StarAHRCVersus Arthritis, UKParkinson's UKFondazione CariploInnovation Fund DenmarkResearch Grants Council, Hong KongUK Research & InnovationGovernment of Argentina
未在任何資料庫公開的文章:9
Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond
E Cuyvers, K Sleegers
The Lancet Neurology 15 (8), 857-868, 2016
授權規定: Research Foundation (Flanders)
Genetic contribution of FUS to frontotemporal lobar degeneration
T Van Langenhove, J Van Der Zee, K Sleegers, S Engelborghs, ...
Neurology 74 (5), 366-371, 2010
授權規定: US National Institutes of Health, Research Foundation (Flanders)
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease
N Brouwers, K Sleegers, S Engelborghs, S Maurer-Stroh, I Gijselinck, ...
Neurology 71 (9), 656-664, 2008
授權規定: Research Foundation (Flanders)
Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
E Cuyvers, A De Roeck, T Van den Bossche, C Van Cauwenberghe, ...
The Lancet Neurology 14 (8), 814-822, 2015
授權規定: Research Foundation (Flanders)
Altered deactivation in individuals with genetic risk for Alzheimer's disease
J Persson, J Lind, A Larsson, M Ingvar, K Sleegers, C Van Broeckhoven, ...
Neuropsychologia 46 (6), 1679-1687, 2008
授權規定: Research Foundation (Flanders)
Molecular pathways of frontotemporal lobar degeneration
K Sleegers, M Cruts, C Van Broeckhoven
Annual review of neuroscience 33 (1), 71-88, 2010
授權規定: Research Foundation (Flanders)
Role of progranulin as a biomarker for Alzheimer's disease
K Sleegers, N Brouwers, C Van Broeckhoven
Biomarkers in medicine 4 (1), 37-50, 2010
授權規定: Research Foundation (Flanders)
Progranulin variability has no major role in Parkinson disease genetic etiology
K Nuytemans, P Pals, K Sleegers, S Engelborghs, E Corsmit, K Peeters, ...
Neurology 71 (15), 1147-1151, 2008
授權規定: Research Foundation (Flanders)
Reduced secretion and altered proteolytic processing caused by missense mutations in progranulin
G Kleinberger, A Capell, N Brouwers, K Fellerer, K Sleegers, M Cruts, ...
Neurobiology of Aging 39, 220. e17-220. e26, 2016
授權規定: Research Foundation (Flanders), German Research Foundation
在某個資料庫公開的文章:161
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452-1458, 2013
授權規定: US National Institutes of Health, National Institute of Health and Medical …
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
D Harold, R Abraham, P Hollingworth, R Sims, A Gerrish, ML Hamshere, ...
Nature genetics 41 (10), 1088-1093, 2009
授權規定: US National Institutes of Health, Research Foundation (Flanders), National …
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
授權規定: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
授權規定: US National Institutes of Health, Research Foundation (Flanders), National …
New insights into the genetic etiology of Alzheimer’s disease and related dementias
C Bellenguez, F Küçükali, IE Jansen, L Kleineidam, S Moreno-Grau, ...
Nature genetics 54 (4), 412-436, 2022
授權規定: US National Institutes of Health, Howard Hughes Medical Institute, National …
The genetic landscape of Alzheimer disease: clinical implications and perspectives
C Van Cauwenberghe, C Van Broeckhoven, K Sleegers
Genetics in Medicine 18 (5), 421-430, 2016
授權規定: Research Foundation (Flanders)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
授權規定: US Department of Defense, US National Institutes of Health, US Department of …
APOE and Alzheimer disease: a major gene with semi-dominant inheritance
E Genin, D Hannequin, D Wallon, K Sleegers, M Hiltunen, O Combarros, ...
Molecular psychiatry 16 (9), 903-907, 2011
授權規定: US National Institutes of Health
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
授權規定: Research Foundation (Flanders), German Research Foundation, European …
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene …
I Gijselinck, T Van Langenhove, J van der Zee, K Sleegers, S Philtjens, ...
The Lancet Neurology 11 (1), 54-65, 2012
授權規定: Research Foundation (Flanders)
Molecular genetics of early-onset Alzheimer's disease revisited
R Cacace, K Sleegers, C Van Broeckhoven
Alzheimer's & dementia 12 (6), 733-748, 2016
授權規定: Research Foundation (Flanders)
出版品和資金資訊是由電腦程式自動估算而得